Insider Transactions in Q4 2021 at Deciphera Pharmaceuticals, Inc. (DCPH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Daniel C. Martin Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,300
+18.67%
|
-
|
|
Dec 15
2021
|
Daniel Lee Flynn Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+27.87%
|
-
|
|
Dec 15
2021
|
Matthew L Sherman EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+16.23%
|
-
|
|
Dec 15
2021
|
Jama Pitman SVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,300
+24.6%
|
-
|
|
Dec 15
2021
|
Thomas Patrick Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+27.88%
|
-
|
|
Oct 04
2021
|
Matthew L Sherman EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,659
-5.46%
|
$87,747
$33.17 P/Share
|